Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated December 31, 2025, titled "SPARC Announces Upcoming R&D Day to Share Strategic Updates on Key Programs and R&D Pipeline".
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SPARC has informed exchanges that it will host an R&D Day on Thursday, January 8, 2026 at 4:00 PM IST via audio conference. The company will share strategic updates on its prioritized programs and the progress of its innovative pharmaceutical pipeline. Investors can participate through dial-in numbers (India toll-free and international numbers for Hong Kong, Singapore, UK, and USA). A management presentation will be available via a webcast link on the day of the call. No new financial numbers or material business decisions were disclosed — this is purely an investor engagement event.
Neutral on the stock in the short term, but the R&D Day itself could be a sentiment catalyst depending on pipeline progress disclosed. Investors should watch for updates on key drug programs, which could influence the stock's direction post-call.